Difficulty: Medium
Average Score: 63%
Practice
The BEST treatment for a 5-year-old boy with Henoch-Schonlein purpura (HSP) presenting with acute onset palpable purpura over the lower extremities and buttocks is
Correct answer
A
Rationale
In treating a 5-year-old boy with Henoch-Schonlein purpura (HSP) presenting with acute onset palpable purpura over the lower extremities and buttocks, the BEST treatment is supportive measures (Option A).
Rationale:
1. Supportive Measures: The primary approach in managing HSP is supportive care, including rest, hydration, and pain management. HSP is a self-limiting condition in most cases, and supportive measures help alleviate symptoms and promote recovery.
Why others are wrong:
1. Steroids (Option B): While steroids may be used in severe cases of HSP with significant renal or gastrointestinal involvement, they are not the first-line treatment for uncomplicated cases like the one described in the question.
2. Azathioprine (Option C) and Cyclophosphamide (Option D): These are immunosuppressive medications that are not typically indicated for initial treatment of uncomplicated HSP in children. They are reserved for cases with severe organ involvement or refractory disease.
Educational context:
Understanding the appropriate treatment for common pediatric conditions like HSP is crucial for pediatric nurses. By opting for supportive measures as the initial management strategy, nurses can provide safe and effective care for children with HSP, promoting positive outcomes and minimizing unnecessary interventions. This knowledge enhances nursing practice and ensures evidence-based care delivery in pediatric settings.
Rationale:
1. Supportive Measures: The primary approach in managing HSP is supportive care, including rest, hydration, and pain management. HSP is a self-limiting condition in most cases, and supportive measures help alleviate symptoms and promote recovery.
Why others are wrong:
1. Steroids (Option B): While steroids may be used in severe cases of HSP with significant renal or gastrointestinal involvement, they are not the first-line treatment for uncomplicated cases like the one described in the question.
2. Azathioprine (Option C) and Cyclophosphamide (Option D): These are immunosuppressive medications that are not typically indicated for initial treatment of uncomplicated HSP in children. They are reserved for cases with severe organ involvement or refractory disease.
Educational context:
Understanding the appropriate treatment for common pediatric conditions like HSP is crucial for pediatric nurses. By opting for supportive measures as the initial management strategy, nurses can provide safe and effective care for children with HSP, promoting positive outcomes and minimizing unnecessary interventions. This knowledge enhances nursing practice and ensures evidence-based care delivery in pediatric settings.